Inbec Tablet

Inbec Tablet – Abacavir (600mg) + Dolutegravir (50mg) + Lamivudine (300mg)

Inbec Tablet is a once-daily fixed-dose combination of Abacavir 600mg, Dolutegravir 50mg and Lamivudine 300mg, manufactured by Emcure Pharmaceuticals Ltd. Dolutegravir, an integrase strand transfer inhibitor, is combined with the NRTIs Abacavir and Lamivudine to provide potent, well-tolerated suppression of HIV-1 replication.

Key Features

• Modern once-daily single-tablet ART regimen, made by Emcure
• Combines the integrase inhibitor Dolutegravir with 2 NRTIs
• Rapid and durable HIV-1 viral load suppression
• High barrier to resistance with once-daily dosing
• Bottle of 30 tablets, Schedule H prescription drug

Composition

• Abacavir (600mg) + Dolutegravir (50mg) + Lamivudine (300mg)

Uses & Benefits

• Used as complete first-line combination therapy for HIV-1 infection
• Provides potent, rapid suppression of HIV viral load
• Supports recovery and maintenance of CD4 cell counts
• Well tolerated with a low incidence of resistance when adherence is maintained
• Prescribed as part of a structured, physician-supervised regimen

Directions for Use

• Take exactly as prescribed by your physician
• Usually taken once daily with or without food
• Swallow the tablet whole with water
• Screening for the HLA-B*5701 gene is generally advised before starting Abacavir-containing regimens

Precautions

• Use only under the supervision of a qualified physician
• Inform your doctor of any kidney or liver conditions before starting treatment
• Regular monitoring of blood counts, liver and kidney function may be required
• Inform your healthcare provider about all other medications you are taking
• Consult your doctor before use during pregnancy or breastfeeding
• Do not skip or stop doses without medical advice, as this may lead to drug resistance

Storage

• Store below 30°C in a cool, dry place
• Keep out of reach of children
• Protect from excessive heat and moisture

Disclaimer

This is a Schedule H prescription medicine. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Do not start, stop or change the dose without consulting a qualified healthcare provider.